And on recent data that suggests we have now begun to observe an inflection in enhanced prescription growth ... As we saw with the addition of enhanced to large express scripts, national formularies ...

Harrow , a leading North American eyecare pharmaceutical company, today announced its first major market access wins in the 2025 Medicare Part D Prescription Drug Program. Starting January 1, 2025, ...

“So, community pharmacists are in a position to improve access to care, because at least 90% of Americans live within five ...